Circulating immune cells in cerebral small vessel disease: a systematic review. [PDF]
Van der Taelen L +5 more
europepmc +1 more source
Correction: SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway. [PDF]
Shu YJ +16 more
europepmc +1 more source
Up-regulation of thrombospondin-1 inhibits the progression of gallbladder cancer. [PDF]
Shu C, Zhou H, Xu J, Tang J, Zhou S.
europepmc +1 more source
TRIM47 is a prognostic biomarker for gallbladder cancer and promotes tumor progression through regulating K63-linked ubiquitination of PARP1. [PDF]
Xu M, Deng C, Man Z, Zhu H.
europepmc +1 more source
BRD9 promotes the progression of gallbladder cancer via CST1 upregulation and interaction with FOXP1 through the PI3K/AKT pathway and represents a therapeutic target. [PDF]
Qiang J +10 more
europepmc +1 more source
NUF2 and NEK2 promote malignant progression of gallbladder cancer by remodeling the extracellular matrix. [PDF]
Gao M, Ye P, Zhang Y, Guo Y, Xu J.
europepmc +1 more source
Trained immunity in acute and chronic neurological diseases. [PDF]
Zhang S, Liesz A.
europepmc +1 more source
Deciphering ERR family genes as prognostic and immunological biomarkers through pan-cancer analysis with validation in gallbladder cancer. [PDF]
Gong W +10 more
europepmc +1 more source
Small nucleolar RNA host gene 1 (SNHG1) facilitates gemcitabine chemosensitivity in gallbladder cancer by regulating the miR-23b-3p/phosphatase and tensin homolog (PTEN) pathway. [PDF]
Wang H +7 more
europepmc +1 more source
LncRNA HOXB-AS3 promotes proliferation, migration, and invasion of gallbladder cancer cells by activating the MEK/ERK pathway. [PDF]
Wu J +7 more
europepmc +1 more source

